The nice people at Transfusion News sent
me quite a lot to think about today. As I said yesterday about something else,
pretty much all COVID-19 related, but I’m not complaining. It is good of them
to do what they do for me, and all for free…
Convalescent Plasma Is Safe and Likely Efficacious for Patients with COVID-19
|
|
 August 4, 2020
There are limited therapeutic options to treat COVID-19, and COVID-19
convalescent plasma (CCP) is currently one of the most common treatments
for patients infected with SARS-CoV-2. However, limited data on
efficacy have been available. Additional data in support of the safety
and efficacy of convalescent plasma from [Read More]
|
|
|
|
Studies Find Variable Anti-SARS-CoV-2 Antibody Responses
|
|
 July 29, 2020
Three recent studies have analyzed anti-SARS-CoV-2 antibodies among
individuals with asymptomatic and mild SARS-CoV-2 infections, and they
have found that antibody responses are variable and short lived. In 37
asymptomatic, RT-PCR positive cases in China (median age 41 years, 40%
male), anti-spike protein IgG levels were significantly [Read More]
|
No comments:
Post a Comment